|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 18889387.9 (espacenet) (Federated) (European Patent Register), 20181210 | Patent/reg. no. and date | DK/EP 3723790, 20240313 | Publication date | 20201021 | Priority no. and date | US 201762597441 P, 20171212 | EP pub. no. and date |
EP 3723790 20201021 | Effective date | | Applicant/owner | Kamada Ltd, 2 Holzman Street Science Park P.O. Box 4081
7670402 Rehovot, IL | Applicant ref. no. | BB247246EPDK | Inventor | TOV, Naveh, 64A Grinboim St., P.O.B. 56324
3491042 Haifa, IL | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | Opponent | | IPC Class | A61K 38/57 (2006.01) , A61K 39/00 (2006.01) , A61P 37/02 (2006.01) | Title | FREMGANGSMÅDER TIL INDUCERING AF IMMUNTOLERANCE OG REDUKTION AF ANTI-LÆGEMIDDEL-ANTISTOFRESPONS | Int. application no. | IL2018051342 | Int. publication no. | WO2019116367 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |